NDC product
Sodium Chloride Hypertonicity Ophthalmic
NDC 0536-1253 · Rugby Laboratories
Key facts
| Product NDC | 0536-1253 |
|---|---|
| Proprietary name | Sodium Chloride Hypertonicity Ophthalmic |
| Nonproprietary name | sodium chloride |
| Substances | SODIUM CHLORIDE |
| Dosage form | OINTMENT |
| Route | OPHTHALMIC |
| Labeler | Rugby Laboratories |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M018 |
| Pharmacologic classes | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| Marketing start | Nov 6, 2020 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: